VALENTINI, GIOVANNA
 Distribuzione geografica
Continente #
NA - Nord America 3.791
AS - Asia 2.714
EU - Europa 2.318
SA - Sud America 293
AF - Africa 91
Continente sconosciuto - Info sul continente non disponibili 48
OC - Oceania 6
Totale 9.261
Nazione #
US - Stati Uniti d'America 3.697
CN - Cina 1.434
SG - Singapore 530
IE - Irlanda 521
UA - Ucraina 336
FI - Finlandia 293
HK - Hong Kong 266
DE - Germania 262
RU - Federazione Russa 225
BR - Brasile 210
VN - Vietnam 198
FR - Francia 145
SE - Svezia 144
IT - Italia 143
GB - Regno Unito 121
IN - India 76
CA - Canada 51
ZA - Sudafrica 49
AR - Argentina 33
BE - Belgio 31
ID - Indonesia 30
MX - Messico 25
NL - Olanda 25
JP - Giappone 24
BD - Bangladesh 22
TR - Turchia 22
IQ - Iraq 21
ES - Italia 14
PK - Pakistan 14
PL - Polonia 13
SA - Arabia Saudita 12
CO - Colombia 11
MA - Marocco 10
EC - Ecuador 8
IR - Iran 8
UZ - Uzbekistan 8
CZ - Repubblica Ceca 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
LT - Lituania 6
MY - Malesia 6
PE - Perù 6
AT - Austria 5
AU - Australia 5
JO - Giordania 5
LV - Lettonia 5
BO - Bolivia 4
DZ - Algeria 4
JM - Giamaica 4
MU - Mauritius 4
NG - Nigeria 4
PA - Panama 4
PH - Filippine 4
PY - Paraguay 4
RO - Romania 4
TN - Tunisia 4
AL - Albania 3
EG - Egitto 3
ET - Etiopia 3
IL - Israele 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
SN - Senegal 3
UY - Uruguay 3
AG - Antigua e Barbuda 2
AZ - Azerbaigian 2
BB - Barbados 2
CH - Svizzera 2
CR - Costa Rica 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GR - Grecia 2
KE - Kenya 2
MD - Moldavia 2
NP - Nepal 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
EU - Europa 1
GM - Gambi 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
ML - Mali 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
Totale 9.211
Città #
Dublin 520
Chandler 505
Jacksonville 372
San Jose 347
Beijing 295
Ashburn 286
Nanjing 270
Hong Kong 260
Singapore 254
Dallas 169
Ann Arbor 152
Boardman 147
Nanchang 131
Los Angeles 111
Helsinki 108
Wilmington 104
Council Bluffs 92
New York 88
Lawrence 85
Medford 85
Princeton 85
Shenyang 76
Lauterbourg 72
Changsha 70
Hebei 70
Munich 68
Ho Chi Minh City 62
Jiaxing 62
Tianjin 62
Hangzhou 61
Hanoi 51
Shanghai 51
Johannesburg 43
Milan 41
Buffalo 40
Woodbridge 39
Moscow 36
Brussels 30
Santa Clara 30
Orem 25
São Paulo 25
Verona 25
Tokyo 21
Turku 21
Chennai 17
Denver 17
Redondo Beach 17
Frankfurt am Main 15
Norwalk 15
Atlanta 14
Chicago 14
Dearborn 14
Falls Church 14
Montreal 14
Pavia 14
Boston 13
Brooklyn 13
Toronto 13
London 12
Phoenix 12
Auburn Hills 11
Da Nang 11
Jinan 11
Mexico City 11
The Dalles 11
Warsaw 11
Haiphong 10
Mumbai 10
Piscataway 10
Des Moines 9
Fairfield 9
Houston 9
Seattle 9
Stockholm 9
Tappahannock 9
Amsterdam 8
Buenos Aires 8
Tashkent 8
Ankara 7
Curitiba 7
Kunming 7
Lahore 7
Rio de Janeiro 7
Taizhou 7
Baghdad 6
Columbus 6
Jakarta 6
Manchester 6
Ningbo 6
Nuremberg 6
San Francisco 6
Bari 5
Cleveland 5
Falkenstein 5
Fuzhou 5
Hải Dương 5
Istanbul 5
Jeddah 5
Kiel 5
Lima 5
Totale 6.078
Nome #
Absence of interaction between doppel and GFAP, Grb2, PrPC proteins in human tumor astrocytic cells 169
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 160
Aberrant Doppel Protein Expression in Human Astrocytic Tumors 154
Divergent biding sites in pyruvate kinase I and II from Escherichia coli. 149
Letter to the editor regarding Shibayama et al.: Biochemical and pathophysiological characterization of Helicobacter pylori asparaginase. 148
Cell-cycle inhibition by Helicobacter pylori L-asparaginase. 139
An essential lysine in the substrate-binding of ornithine carbamoyl transferase 138
Generation of Mutants of Helicobacter pylori L-Asparaginase 136
Primary structure of three peptides at the catalytic and allosteric sites of the fructose 1,6-bisphosphate-activated pyruvate kinase from Escherichia coli 136
The prion-like doppel protein is soluble in astrocytic tumor 135
Phosphoglycerate Kinase Deficiency: Characterization of the Wild-Type Enzyme and Three Pathological Variants Generated from C.140T>a, C.491A>T and C.959G>a Mutations 135
Engineering of Helicobacter pylori L-asparaginase: characterization of two functionally distinct groups of mutants 135
A simple procedure for the purification of neutral salt soluble type I collagene from skin. 134
Molecular and cellular insights into the aberrant expression of the prion protein-like gene doppel in astrocytic tumors 132
Fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli: ligands promoted conformational changes 131
Expanding targets for a metabolic therapy of cancer: L-asparaginase 131
Biochemistry of Lipolytic Enzymes Secreted by Penicillium solitum and Cladosporium cladosporioides 130
Mycobacterium tuberculosis Phosphoribosylpyrophosphate Synthetase: Biochemical Features of a Crucial Enzyme for Mycobacterial Cell Wall Biosynthesis. 129
Crystallization and preliminary X-ray analysis of pyruvate kinase type I from Escherichia coli. 129
Expanding Targets for a Metabolic Therapy of Cancer: L- Asparaginase 126
Affinity labelling of the catalytic and allosteric ATP binding sites on pyruvate kinase type I from Escherichia coli. 125
The prion protein-like gene Doppel is aberrantly expressed in astrocytic tumors 125
Ectopic expression of the prion-like protein doppel in human astrocytoma cells 125
Crystal structure of Escherichia coli pyruvate kinase type I: molecular basis of the allosteric transition 124
Bacterial pyruvate kinases have a shorter N-terminal domain 122
Clinical Severity of PGK1 Deficiency Due To a Novel p.E120K Substitution Is Exacerbated by Co-inheritance of a Subclinical Translocation t(3;14)(q26.33;q12), Disrupting NUBPL Gene. 122
AMP- and fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli. 121
Pyruvate kinase deficiency: Biochemical characterization of two mutations causing inability of the enzyme to properly bind substrates 121
The allosteric regulation of pyruvate kinase. 121
Recombinant pyruvate kinase type I from Escherichia coli:overproduction and revised C-terminus of the polypeptide 120
Influence of fibronectine on the fibrillogenesis of type I and type III collagen 120
A new mutation of the pgk1 gene detected in an italian patient affected by phosphoglycerate kinase deficiency. 120
Biochemical signatures of doppel (Dpl) protein in human glioblastoma to support prediction in tumor malignancy 119
A comparative study on liver ornithine carbamoyl transferase from a marine mammal Stenella and a elasmobranch Sphyrna zygaena. 118
Helicobacter pylori L-asparaginase: from Gene to Diagnostic Tool 118
Nuclear mRNA retention and aberrant doppel protein expression in human astrocytic tumor cells 117
Rapid detection of ornithine transcarbamylase activity by micellar electrokinetic chromatography. 116
Helicobacter pylori: from gene to Diagnostic Tool 115
Molecular Insights on Pathogenic Effects of MutationsCausing Phosphoglycerate Kinase Deficiency 115
Two forms of pyruvate kinase in Escherichia coli. A comparison of chemical and molecular properties 113
Molecular cloning and characterisation of Helicobacter pylori L-asparaginase 113
Fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli. Natures of bonds involved in the allosteric mecchanism. 112
A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement: molecular and functional characterization. 112
Characterization of a pyrimidine 5'-nucleotidase mutant form (G214R) causing hereditary hemolytic anemia. 111
Micellar electrokinetic chromatography as a complementary method to sodium dodecyl sulfate-polyacrylamide gel electrophoresis for studying limited proteolysis of proteins. 110
Reactivity of the fructose 1,6-biphosphate-activated pyruvate kinase from Escherichia coli with pyridoxal 5’-phosphate 109
SELECTION OF MICROFUNGI WITH HIGH LIPOLYTIC ACTIVITYAND THEIR LIPASE CHARACTERIZATION 109
Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia 108
Premio Ricercatissimi 2008 106
PHOSPHOGLYCERATE KINASE DEFICIENCY: FUNCTIONAL PROPERTIES OF THE L89P, K191DEL, C316R AND A354P PATHOLOGICAL VARIANTS 103
Investigating the Molecular Bases of the Phosphoglycerate Kinase Deficiency: Characterization ofG158V, R206P, V266M and D285V Pathological Variants. 102
Erythrocyte adenylate kinase deficiency: characterization of recombinant mutant forms and relationship with nonspherocytic hemolytic anemia 100
Molecular Characterization of Three New Mutant Enzymes of Pyrimidine 5-Nucleotidase Causing Hereditary Hemolytic Anemia. 98
EXPRESSION AND CHARACTERIZATION OF THE BOVINE PRION DOPPEL 97
Erythrocyte Adenylate Kinase Deficiency: First In-Depth Biochemical Characterization of the Y164C Mutant Enzyme Causing Hemolytic Anemia 96
Pyrimidine 5' Nucleotidase Deficiency: Clinical and Molecular Characterization of Two New Italian Patients 96
Purification and molecular properties of the AMP-activated pyruvate kinase from Escherichia coli. 95
Aeroplane shaped crystal of a mutant ofHelicobacter pylori L-asparaginase. 95
Molecular basis of pyrimidine 5'-nucleotidase deficiency caused by 3 newly identified missense mutations (c.187T>C, c.469G>C and c.740T>C) and a tabulation of known mutations 95
Human erythrocyte pyruvate kinase:characterization of the recombinant enzyme and a mutant form(R510Q))causing nonspherocytic hemolytic anemia. 94
Molecular and functional characterization of a lethal variant of pyruvate kinase deficiency 92
Pyrimidine 5'-nucleotidase activities detected in real samples by means of micellar electrokinetic chromatography. 92
Red cell pyruvate kinase deficiency: molecular and clinical aspects 90
Inosine monophosphate dehydrogenase activity after mycophenolate mofetil in renal transplant patients receiving different immunosupressive combined therapy and stable after at least three months' administration. 90
Molecular Basis of Hemolytic Anemia: First Biochemical Characterization of Wild-Type and N190S Mutant Human Erythrocyte Pyrimidine 5'-Nucleotidase. 90
PYRUVATE KINASE DEFICIENCY: MOLECULAR AND FUNCTIONAL CHARACTERISATION OF A LETHAL VARIANT 89
Structural and Energetic Basis of Protein Kinetic Destabilization in Human Phosphoglycerate Kinase 1 Deficiency 88
The allosteric regulation of pyruvate kinase 87
Functional and structural characterization of ovine ornithine transcarbamoylase 87
Hereditary pyrimidine 5'-nucleotidase deficiency: from genetics to clinical manifestations. 87
Pyruvate kinase deficiency : The genotype-phenotype association 87
Red cell pyruvate kinase deficiency: 17 new mutations of the PK-LR gene 86
Two new mutations of the P5'N-1 gene found in Italian patients with hereditary hemolytic anemia: the molecular basis of the red cell enzyme disorder. 84
Functional analysis of pyrimidine 5'-nucleotidase mutants causing nonspherocytic hemolytic anemia 83
Hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency: a biochemical, genetic and clinical overview 83
L-ASPARAGINASE FROM HELICOBACTER PYLORI 80
Protein Stability, Folding and Misfolding in Human PGK1 Deficiency 80
The interplay between protein stability and folding co-operativity in loss-of-function genetic disease: The case of human PGK1 deficiency. 80
Functional Analysis of Two Mutants of Pyrimidine 5’ Nucleotidase Causing Nonspherocytic Hemolytic Anemia 80
Molecular Cloning and Characterisation of Helicobacter Pylori L-Asparaginase: A Cytotoxic Factor with Potential Biomedical Applications 79
Tackling Critical Catalytic Residues in Helicobacter pylori L-Asparaginase 77
Monitoring Inosine monophosphate dehydrogenase (IMPDH) in kidney transplant recipients 71
Helicobacter pylori L-asparaginase: A promising chemotherapeutic agent 70
Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy 60
Protein stability, folding and misfolding in human PGK1 deficiency 35
Totale 9.261
Categoria #
all - tutte 36.950
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.950


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022444 0 7 9 6 26 17 15 32 32 20 51 229
2022/20231.411 124 122 9 128 157 155 1 64 594 8 32 17
2023/2024516 121 70 6 43 50 141 7 32 0 12 20 14
2024/20251.228 28 97 45 44 32 52 41 73 322 23 179 292
2025/20262.917 234 197 300 370 357 162 502 111 304 210 86 84
2026/2027168 50 118 0 0 0 0 0 0 0 0 0 0
Totale 9.261